Picture of TRACON Pharmaceuticals logo

TCON TRACON Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for TRACON Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-22.7-16.8-28.7-29.1-3.59
Depreciation
Non-Cash Items1.881.171.543.129.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2.88-1.454.54-0.239-2.15
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-23.6-17-22.6-26.23.68
Capital Expenditures0-0.005-0.048-0.0170
Purchase of Fixed Assets
Other Investing Cash Flow Items14-4400
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities14-43.95-0.0170
Financing Cash Flow Items-0.023.43
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.90636.810.619.7-12.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8.7215.7-8.06-6.57-8.86